Authors:
Centanni, S
Carlucci, P
Santus, P
Boveri, B
Tarricone, D
Fiorentini, C
Lombardi, F
Cazzola, M
Citation: S. Centanni et al., Non-pulmonary effects induced by the addition of formoterol to budesonide therapy in patients with mild or moderate persistent asthma, RESPIRATION, 67(1), 2000, pp. 60-64
Citation: M. Cazzola et Cf. Donner, Long-acting beta(2) agonists in the management of stable chronic obstructive pulmonary disease, DRUGS, 60(2), 2000, pp. 307-320
Authors:
Cazzola, M
Noschese, P
D'Amato, M
D'Amato, G
Citation: M. Cazzola et al., Comparison of the effects of single oral doses of nebivolol and celiprololon airways in patients with mild asthma, CHEST, 118(5), 2000, pp. 1322-1326
Authors:
Lucotti, C
Malabarba, L
Rosti, V
Bergamaschi, G
Danova, M
Invernizzi, R
Pecci, A
Ramajoli, I
Perotti, C
Torretta, L
De Amici, M
Salvaneschi, L
Cazzola, M
Citation: C. Lucotti et al., Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycle, BR J HAEM, 108(3), 2000, pp. 621-628
Authors:
Cazzola, M
May, A
Bergamaschi, G
Cerani, P
Rosti, V
Bishop, DF
Citation: M. Cazzola et al., Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females, BLOOD, 96(13), 2000, pp. 4363-4365
Authors:
Cazzola, M
Vinciguerra, A
Di Perna, F
Califano, C
Calderaro, F
Salzillo, A
Centanni, S
Citation: M. Cazzola et al., Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis, J CHEMOTHER, 11(2), 1999, pp. 119-125
Authors:
Mazzaglia, G
Arcoraci, V
Greco, S
Cucinotta, G
Cazzola, M
Caputi, AP
Citation: G. Mazzaglia et al., Prescribing habits of general practitioners in choosing an empirical antibiotic regimen for lower respiratory tract infections in adults in Sicily, PHARMAC RES, 40(1), 1999, pp. 47-52
Citation: M. Cazzola et Mg. Matera, Should long-acting beta(2)-agonists be considered an alternative first choice option for the treatment of stable COPD?, RESP MED, 93(4), 1999, pp. 227-229
Authors:
Cazzola, M
Matera, MG
Di Perna, F
Califano, C
D'Amato, M
Mazzarella, G
Citation: M. Cazzola et al., Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD, RESP MED, 93(12), 1999, pp. 909-911
Citation: M. Cazzola et Mg. Matera, Inhaled oxitropium bromide is currently used as the first-line therapy of patients with chronic pulmonary disease in Japan - Reply, EUR RESP J, 13(2), 1999, pp. 474-475
Authors:
Rovati, A
Bergamaschi, G
Casula, S
Cerani, P
Grasso, M
Cazzola, M
Citation: A. Rovati et al., The dysmetabolic iron overload syndrome is clinically and genetically distinct from HFE-related genetic hemochromatosis, HAEMATOLOG, 84(2), 1999, pp. 182-183
Authors:
Barosi, G
Marchetti, M
Alessandrino, P
Locatelli, F
Casula, S
Lunghi, M
Cazzola, M
Giraldi, E
Bernasconi, C
Citation: G. Barosi et al., A model for analysing the cost of autologous peripheral blood progenitor cell (PBPC) transplantation, BONE MAR TR, 23(7), 1999, pp. 719-725
Authors:
Cerutti, A
Custodi, P
Duranti, M
Cazzola, M
Balduini, CL
Citation: A. Cerutti et al., Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant, CLIN LAB H, 21(4), 1999, pp. 271-275
Citation: M. Cazzola et al., Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease, THORAX, 54(8), 1999, pp. 730-736
Authors:
Cazzola, M
Di Perna, F
Centanni, S
Califano, C
Donner, CF
D'Amato, M
D'Amato, G
Citation: M. Cazzola et al., Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease, THORAX, 54(12), 1999, pp. 1083-1086
Authors:
Cazzola, M
Calderaro, F
Califano, C
Di Pema, F
Vinciguerra, A
Donner, CF
Matera, MG
Citation: M. Cazzola et al., Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease, EUR J CL PH, 54(11), 1999, pp. 829-833
Citation: Cr. Allerson et al., Clinical severity and thermodynamic effects of iron-responsive element mutations in hereditary hyperferritinemia-cataract syndrome, J BIOL CHEM, 274(37), 1999, pp. 26439-26447
Authors:
Cazzola, M
Beguin, Y
Bergamaschi, G
Guarnone, R
Cerani, P
Barella, S
Cao, A
Galanello, R
Citation: M. Cazzola et al., Soluble transferrin receptor as a potential determinant of iron loading incongenital anaemias due to ineffective erythropoiesis, BR J HAEM, 106(3), 1999, pp. 752-755
Authors:
Frassoni, F
Podesta, M
Piaggio, G
Rosti, V
Pitto, A
Benvenuto, F
Figari, O
Vassallo, F
Carella, AM
Zikos, P
Bergamaschi, G
Fugazza, G
Sessarego, M
Cazzola, M
Citation: F. Frassoni et al., Normal primitive haemopoietic progenitors are more frequent than their leukaemic counterpart in newly diagnosed patients with chronic myeloid leukaemia but rapidly decline with time, BR J HAEM, 104(3), 1999, pp. 538-545
Authors:
Cotter, PD
May, A
Li, LP
Al-Sabah, AI
Fitzsimons, EJ
Cazzola, M
Bishop, DF
Citation: Pd. Cotter et al., Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: Increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis, BLOOD, 93(5), 1999, pp. 1757-1769